2Perwad F,Zhang M Y.Fibroblast growth factor 23 impairs phosphorus and Vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin expression in vitro[J].Am J Physiol Renal Physiol,2007,293(5):1577-1583.
3Hoshino G,Satoth N,Sugawara S,et al.Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23[J].Inter Med,2008,47(5):453-457.
4Fukumoto S.Physiological regulation and disorders of phosphate metabolism (pivotal role of fibroblast growth factor 23[J].Inter Med,2008,47(5):337-343.
4Andrew L, Folp M D, Julie C. et al . Most osteommalacia-associated mesenchymal tummors are a single histopathologic entity[ J ]. America J Surg Pathology ,2004,28 ( 1 ) : 1-30.
5Jande S M, Levine M A. Molecular pathogenesis of hypophosphatemic tic kets [J].J Clin Endocrinol Metab, 2002., 87 ( 6 ) ; 2467 -2473.
6Econs M J, McEnery P T. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder[J]. J Clin Endorinol M etab, 1997,82 ( 2 ) : 674-681.
7Murer H. Hernando N, Forster I, et al. Proximal tubular phosphate reabsorption : molecular mechanisms [ J ]. Physiol Rev, 2000,80 ( 4 ) : 1373 -1409.
8Kumar R. Phosphatonin-A new phoaphsturetic hormone [ J]. N ephrol Tranaplant, 1997,12 ( 1 ) : 11 -13.
9White K E,Jonsson K B,Carn G,et al. The ADHR gene is a secreted polypeptide over-expressed by tumors that cause phosphate wasting [ J ]. J Clin Endocrinol Metab, 2001 , 86 (2) :497-500.
10Shimada T, Mizutani S, Muto T, et al. Cloning and characterizaauon of FGF-23 as a causative facter oftumer induced osteomalacia [J].Proc Natl Acad Sci USA, 2001,98 ( 11 ) : 6500-6505.
